3-(2-{[2-(2-Amino-acetylamino)-3-(1H-indol-3-yl)-propionyl]-methyl-amino}-hexanoylamino)-N-(1-carbamoyl-2-phenyl-ethyl)-succinamic acid

InChIKey	`CXNFPROZKYIEPE-FWEHEUNISA-N`
Compound Name	3-(2-{[2-(2-Amino-acetylamino)-3-(1H-indol-3-yl)-propionyl]-methyl-amino}-hexanoylamino)-N-(1-carbamoyl-2-phenyl-ethyl)-succinamic acid
Canonical SMILES	`CCCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)N(C)C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	2
Pfam Stratification	Homologous
Avg pChEMBL	8.48
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P32238	CCKAR	Homo sapiens	Human	PF00001 PF09193	8.5	pIC50	TTD_MultiTarget
P32239	CCKBR	Homo sapiens	Human	PF00001	8.5	IC50	ChEMBL;BindingDB